Search

everythinglearnresearchcommunity

for

Search:↓

Tectoridin helps human hair cells grow and makes mouse hair longer, suggesting it could treat hair loss.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Taurine may help reduce hair loss by improving hair growth cycles.

The A-T advancement flap is a safe and effective method for scalp reconstruction after basal cell carcinoma removal.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Tofacitinib effectively treats Alopecia Areata.

Combining botulinum toxin type A with Minoxidil leads to better hair growth and quality of life in men with hair loss.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

Baricitinib can cause excessive hair growth.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib shows promise in treating severe hair loss.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.